Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transient receptor potential cation channel subfamily A member 1 (TRPA1), widely recognized as the 'chemical irritant receptor,' is a non-selective cation channel primarily expressed in the plasma membrane of nociceptive sensory neurons (UniProt O75762). It functions as a versatile sensor for a broad range of exogenous chemical irritants—such as those found in mustard oil, garlic, and cigarette smoke—as well as endogenous products of oxidative stress and lipid peroxidation (PubMed PMID: 24336214). Upon activation, TRPA1 allows the influx of calcium and sodium ions, triggering neuronal depolarization and the subsequent sensation of pain, itch, or respiratory irritation. In clinical contexts, TRPA1 is heavily implicated in the pathophysiology of chronic airway diseases like asthma and chronic obstructive pulmonary disease (COPD), where it mediates airway hyperresponsiveness and neurogenic inflammation (Nature Reviews Drug Discovery, doi:10.1038/nrd4285). Consequently, TRPA1 has emerged as a high-priority therapeutic target, with several pharmaceutical companies developing small-molecule antagonists to treat neuropathic pain, inflammatory disorders, and refractory cough.
TRPA1 antagonists inhibit the channel to reduce the influx of cation-mediated depolarization in sensory neurons, thereby alleviating pain and inflammation; agonists are used as research tools or in sensory testing to activate the channel.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential cation channel subfamily A member 1 (TRPA1) (TRPA1).